Article Details

Hillstream BioPharma Receives Orphan Drug Designation for - GlobeNewswire

Retrieved on: 2022-02-17 02:44:25

Tags for this article:

Click the tags to see associated articles and topics

Hillstream BioPharma Receives Orphan Drug Designation for - GlobeNewswire. View article details on hiswai:

Excerpt

Hillstream BioPharma Receives Orphan Drug Designation for HSB-1216 for the Treatment of Uveal Melanoma. February 16, 2022 09:40 ET | Source: ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up